Diagenode is Proud to Announce Its Participation in Cell-O-Matic, an Exciting Programme About Single Cell Genomics
(firmenpresse) - LIEGE, BELGIUM -- (Marketwire) -- 03/20/12 -- Cell-O-Matic (High Throughput Systematic Single-cell Genomics using Micro/Nano-Fluidic Chips for Extracting, Pre-analysis, Selecting and Preparing Sequence-ready DNA) consortium is made up of 13 partners - 2 academic research groups, 9 SME's and 2 industries - from 8 different member states and funded by the seventh Framework FP-HEALTH.2011. This consortium will aim at developing methods that enable whole chromosome lengths of DNA to be contiguously mapped using nanofluidics. The Cell-0-Matic project will also synergize efforts to develop chip-based technologies that process DNA from individual cells, ready for Next-Generation high-throughput sequencing. Helene Pendeville Ph.D., R&D Manager Associate noted: "Improving the quality and throughput of sequencing technologies to access genome information at a single-cell level will have a profound impact on systems biology, including cancer. Diagenode is proud to be part of this exciting 4-year programme."
About Diagenode
Diagenode is a multinational life science company that develops and commercializes innovative instruments and reagents for epigenetic research. Major product lines include SX-8G IP-Star® Automation, Bioruptor® Sonication, epigenetic targeted ChIP-seq grade antibodies, kits for Chromatin Immunoprecipitation and DNA methylation studies. Founded in 2004 in Liege (Belgium), Diagenode has offices in Liege, Belgium and Denville, New Jersey.
Contacts:
Diagenode sa
Helene Pendeville
R&D Manager Associate
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.03.2012 - 15:20 Uhr
Sprache: Deutsch
News-ID 126658
Anzahl Zeichen: 0
contact information:
Town:
LIEGE, BELGIUM
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 162 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Diagenode is Proud to Announce Its Participation in Cell-O-Matic, an Exciting Programme About Single Cell Genomics"
steht unter der journalistisch-redaktionellen Verantwortung von
Diagenode sa (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
